临床荟萃

• 荟萃分析 • 上一篇    下一篇

Ⅲ期结直肠癌术后起始化疗的最适时间点荟萃分析

  

  1. 华中科技大学同济医学院附属同济医院 胃肠外科,湖北  武汉 430014
  • 出版日期:2018-04-05 发布日期:2018-04-24
  • 通讯作者: 通信作者:冯永东,Email: ydfeng@tjh.tjmu.edu.cn

Optimal time of initiating adjuvant chemotherapy for Ⅲ postoperative colorectal neoplama metaanalysis

  1. Department of  Gastrointestinal Surgery, Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology,  Wuhan 430014,  China
  • Online:2018-04-05 Published:2018-04-24
  • Contact: Corresponding author: Feng Yongdong, Email: ydfeng@tjh.tjmu.edu.cn

摘要: 目的 系统评价Ⅲ期结直肠癌患者首次术后化疗(PAC)的最佳时间间隔点,并探讨术后并发症对间隔点的影响。方法 检索Cochrane Library,PubMed,Web of Sience, China National Knowledge Internet(CNKI) 数据库。用森林图法系统性分析不同时间起始PAC与Ⅲ期结直肠癌患者临床预后的关联,统计相关的总体存活率(OS),无复发存活率(RFS),并讨论术后并发症对首次PAC时间间隔的影响。结果 共11篇文献纳入研究,总计47 775例患者(男26 499例;女21 276例)。发现以8周为分界,PAC时间间隔>8周时OS明显下降(OR=1.75,95%CI=1.352.25,P<0.01)。以不同的PAC时间间隔为界, OS同样会随着PAC的延长而明显下降(OR=1.55,95%CI=1.23~1.93,P=0.01),但RFS不会随之下降(P=0.10)。术后并发症成为起始PAC延期的关键因素之一(OR=2.45,95%CI=1.19~5.01,P=0.01)。结论  Ⅲ期结直肠癌患者术后首次PAC应在8周内进行。延期PAC会导致不良的OS,而对RFS没有明显影响。对于术后并发症的良好控制,是保证PAC按时进行的必要条件。

关键词: 结直肠肿瘤, 手术后并发症, 放化疗, 辅助, 预后

Abstract: Objective  To gain access to the suitable interval of postoperative adjuvant chemotherapy(PAC) for stage Ⅲ colorectal cancer patients by metaanalysis and identify the effects of postoperative complications on interval  as well.  Methods  Casecontrol studies assessing the interval time between curative resection surgery and first PAC for Ⅲ CRC patients  were identified from Cochrane Library, PubMed, Web of Science, China National Knowledge Internet(CNKI). Overall Survival(OR),  RelapseFree Survival(RFS),  as well as the associations between postoperative complications and interval were concluded and statistically analyzed by Forest Plot.Results  Eleven casecontrol studies which covered a total of 47 775 patients(26 499 males;21 276 females)were contained in this  metaanalysis.  We chose eight weeks for the cutoff,beyond which was related to worse OS(OR=1.75;95% CI=1.352.25,P<0.01). If a variety of cutoffs were included,longer delay was similarly associated to a worse OS(OR=1.55,95%CI=1.231.93,P=0.0001),  but not a worse RFS(P=0.10). Postoperative complications became a key point of the delays of PAC(OR=2.43,95%CI=1.194.96,P=0.01). Conclusion  The first PAC should be performed within eight weeks in patients with stage Ⅲ colorectal cancer. Delayed PAC results in poor OS, while RFS has no significant impact. Effective control of postoperative complications is a necessary factor to ensure PAC on schedule.

Key words: colorectal neoplasm;postoperative complications; adjuvant , chemoradiotherapy;prognosis